Back to Trades
Muken Ross
Chief Executive OfficerDirectorCIK 0002005463
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 9
- Companies
- 1
- Active
- 2026
Muken Ross, Chief Executive Officer, Director, has filed 9 SEC reports (2026), all concentrated in SOPHiA GENETICS SA (SOPH), totaling $6.5M in disclosed volume. Weighing $0 bought versus $143.2K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 7 | SOPH SOPHiA GENETICS SA | Muken Ross | Chief Executive Officer, Director | Sell | $51.4K |
| Jun 23 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Sell | $2.3K |
| Apr 21 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Sell | $4.0K |
| Apr 14 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Sell | $38.4K |
| Apr 10 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Sell | $22.7K |
| Apr 8 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Sell | $24.4K |
| Apr 8 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Grant | $3.2M |
| Apr 3 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Grant | $3.2M |
| Mar 18 | SOPH SOPHiA GENETICS SA | Muken Ross | President | Other | $0 |
9 filings